Pancreatic Cell News Volume 13.07 | Feb 22 2022

    0
    31






    2022-02-22 | PACN 13.07


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 13.07 – 22 February, 2022
    TOP STORY

    A Two-Phase Approach to Fusicoccane Synthesis to Uncover a Compound That Reduces Tumorigenesis in Pancreatic Cancer Cells

    Scientists generated 15 g of a tricyclic intermediate in 8 steps from (R)-limonene and 720 mg of a penultimate bioactive intermediate in a protecting-group-free manner.
    [Angewandte Chemie-International Edition]

    Abstract

    Explore tools and resources for your return to the lab
    PUBLICATIONSRanked by the impact factor of the journal

    Cadmium Exposure Suppresses Insulin Secretion through mtROS-Mediated Mitochondrial Dysfunction and Inflammatory Response in Pancreatic Beta Cells

    The authors used an in vitro MIN6 cell model of environment-relevant cadmium exposure to elucidate the crucial role of mtROS-mediated mitochondrial dysfunction and inflammatory response in the suppression of pancreatic β-cell insulin secretion.
    [Journal of Trace Elements in Medicine and Biology]

    AbstractGraphical Abstract

    Excess Fatty Acids Induce Pancreatic Acinar Cell Pyroptosis through Macrophage M1 Polarization

    Scientists found that palmitic acid stimulation led to M1 polarization of macrophage, which secreted cathepsin S via exosomes to pancreatic acinar cells and led to activation of the caspase1-mediated classical pyrolysis pathway.
    [BMC Gastroenterology]

    Full Article

    A Comparison of 64Cu-Labeled Bi-Terminally PEGylated A20FMDV2 Peptides Targeting Integrin ανβ6

    Researchers described the radiolabeling, in vitro and in vivo evaluation of a bi-terminally PEGylated A20FMDV2 conjugated with DOTA or PCTA for 64Cu radiolabeling.
    [Oncotarget]

    Full Article

    circCUL2 Induces an Inflammatory CAF Phenotype in Pancreatic Ductal Adenocarcinoma via the Activation of the MyD88-Dependent NF-κB Signaling Pathway

    Investigators investigated the effect of circCUL2 on inflammatory cancer-associated fibroblast activation, heterogeneity and protumor activity by ELISA, flow cytometry, colony formation and transwell assays in vitro and by xenograft models in vivo.
    [Journal of Experimental & Clinical Cancer Research]

    Full Article

    Effects of Hyperinsulinemia on Pancreatic Cancer Development and the Immune Microenvironment Revealed through Single-Cell Transcriptomics

    Scientists performed thorough histopathological analyses and single-cell transcriptomics for both genotypes, Ptf1aCreER;KrasLSL-G12D and sexes.
    [Cancer & Metabolism]

    Full Article

    A Novel Chemo-Phenotypic Method Identifies Mixtures of Salpn, Vitamin D3, and Pesticides Involved in the Development of Colorectal and Pancreatic Cancer

    Researchers described a novel computational method for characterizing toxicity, associated biological perturbations and disease outcome, called the Chemo-Phenotypic Based Toxicity Measurement. The method was validated in the in vitro, in vivo and organoid models.
    [Ecotoxicology and Environmental Safety]

    Abstract

    CCL2-Mediated Monocytes Regulate Immune Checkpoint Blockade Resistance in Pancreatic Cancer

    Scientists found that C-C motif chemokine ligand 2 (CCL2) recruited monocytes to and decrease CD8+ T cell infiltration in pancreatic tumors.
    [International Immunopharmacology]

    Abstract

    Circ_0072008, an Oncogene in Pancreatic Ductal Adenocarcinoma, Contributes to Tumour Cell Malignant Progression and Glycolysis by Regulating miR-545-3p/SLC7A11 Axis

    Expression of circ_0072088, microRNA (miR)-545-3p and solute carrier family 7 member 11 (SLC7A11) was detected by real-time quantitative PCR and western blotting.
    [Autoimmunity]

    Full Article

    How to prioritize and manage your research projects
    REVIEWS

    Clinical Significance of Pancreatic Ductal Metaplasia

    Pancreatic ductal metaplasia (PDM) development might involve all cell lineages of the pancreas, and acinar cells with the highest plasticity are the major source of PDM.
    [Journal of Pathology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Kiniksa Pharmaceuticals and Huadong Medicine Announce Strategic Collaboration

    Kiniksa Pharmaceuticals, Ltd. and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., announced a strategic collaboration to develop and commercialize Kiniksa’s ARCALYST® and mavrilimumab in the Asia Pacific Region.
    [Kiniksa Pharmaceuticals, Ltd.]

    Press Release

    FEATURED EVENT

    Next Generation Kinase Inhibitor Summit

    29 – 31 March, 2022
    Boston, Massachusetts, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Pancreatic Beta Cell

    OU Health Sciences Center – Oklahoma City, Oklahoma, United States

    Postdoctoral Position – β-Cell Regeneration

    Karolinska Institute – Stockholm, Sweden

    Post-Doctoral Researcher – Anti-Diabetic Drug

    University of Pennsylvania – Philadelphia, Pennsylvania, United States

    Postdoctoral Fellow – Cancer Immune Biomarkers

    Albert Einstein College of Medicine – Bronx, New York, United States

    Postdoctoral Position – Proteome Dynamics

    University of Texas Medical Branch – Galveston, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter